The answer is, fortunately, yes! The scientific data that is available already shows that CBD is emerging as a new class of drugs that treat infections of bacteria, fungi and virus by different mechanisms of action not found in any other class of drug (Ref 1).
Does our body respond to Corona virus the same way it would respond to other virus invaders?
The very latest research coming from Doherty Institute of Infection and Immunity in Australia led by the Polish Immunologist PHD, Prof. Katherine Kędzierski shows the classic response of human immune system to Covid-19 virus (Ref 5). This is truly great news! Our immune system responds to this unknown invader, the way it would respond to any other known to us virus, which shows that our body is prepared for dealing with it and can fight it like any other virus intruder. That’s why boosting and supporting our immune system is the key to our body fighting and surviving Corona virus as well.
So how our immune system works to protect itself from foreign invaders, including the Corona virus?
Our immune system is in a constant complex balancing act between our organs, cells and tissues to keep it at top health level at all times. In 1992, at the Hebrew University in Jerusalem, Dr. Lumir Hanus along with American researcher Dr. William Devane discovered naturally occurring neurotransmitters called endocannabinoids. That led to further discovery that all our bodily functions are regulated by our internal ECS – Endocannabinoid System. The ECS system is a self-healing mechanism present in all mammals and is responsible for maintaining our body’s “homeostasis” – a biological balance in a given environment. The ECS regulates all of our bodily functions and physiological processes, including the immune function and inflammation – via network team of endocannabinoids, cannabinoid receptors (CB1 & CB2) and enzymes that in turn activate the white blood cells to fight and get rid off dangerous intruders.
“The discovery and application of the Endocannabinoid Signalling System is proving to be the control of virtually all diseases of mankind.” Dr. David Allen, ICRS
Our body produces endocannabinoids to help modulate or regulate cell function, including the cells in our immune system. When an imbalance is detected within our internal environment, the body synthesizes endocannabinoids that interact with the cannabinoid receptors. This stimulates a chemical response that brings back the physiological processes back to homeostasis. However, in some cases, there is a deficiency in ECS signaling. This condition is known as Clinical Endocannabinoid Deficiency. Reasons to as why this condition occurs can be anything from our body not synthesising enough endocannabinoids, having not enough cannabinoid receptors, as well as outside sources such as medication, food or environmental factors that decrease ECS signalling. The phytocannabinoids contained in cannabis can be used to supplement this deficiency. CBD – a non-psychoactive compound and other phytocannabinoids that come from cannabis plant stimulate our natural ECS system to work more efficiently and keep any inflammatory responses under control.
Endocannabinoids – The fatty substances or oils (in microscopic quantities) that bind with body’s own cannabinoid receptors. They are manufactured, controlled and disposed of by the enzymes. Our body manufactures endocannabinoids in order to pass messages concerning functions such as pain, inflammation, memory, appetite and mood. Endocannabinoids modulate cell activity on demand traveling across chemical synapses. They act upon immune cells directly through cannabinoid receptors.
Cannabinoid receptors – are the membranes in our body’s cells that enable signals to be passed around. There are CB1 and CB2 receptors in the central nervous system and CB2 receptors in the immune and and the peripheral nervous system.
CBD and other cannabinoids that come from cannabis plant stimulate our natural ECS system to work more efficiently and keep it under control via CB2 receptors present in our immune system.
What evidence is that CBD helps the immune system?
Dr David Allen M.D., a well known Cannabinoid Research Scientist, a member of in a the International Cannabinoid Research Society (ICRS) and former Cardiac Surgeon, in his article “CBD Protective Against Ebola Virus” says that “There is good scientific evidence that cannabinoids, and in particular Cannabidiol (CBD), may offer control of the immune system and in turn provide protection from viral infections. Cannabis has already been recognized to inhibit fungus and bacteria and can be considered a new class of antimicrobial because of the different mechanism of action from other antimicrobials. There are U.S. Patents showing evidence that Cannabinoids have significant anti-viral activity. (Ref 3 & 4)”
He also says “Cannabinoids are proving to have significant cidal (killer) activity to many viruses, including hepatitis C and the HIV virus. Cannabinoids down-regulate (inhibit) the immune response to the infection (Ref 2 & 3). The cited U.S. Patents (Ref 3 & 4) are proof that cannabinoids inhibit many different virus strains from replicating. These patents also prove cannabinoids decreases the body’s immune over stimulated response to the viral infection (* which is one of the problems and the possible cause of death in Ebola virus patients).”
“The US Patents are proof that Cannabinoids inhibit many different virus strains from replicating. These patents also prove cannabinoids decreases the body’s immune over stimulated response to the viral infection.” Dr David Allen M.D., ICRS
It is indeed hard to find any other medicine, natural or artificial, of such wide spectrum of ability to treat various diseases as cannabinoids coming from the simple plant, which are not only effective and safe, but also affordable and accessible to anyone who supports his health with this incredible plant, especially in these difficult times of Corona virus taking its toll.
References:
(1) Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study; Giovanni Appendino et al. The School of Pharmacy, University of London)
(2) Protection Against Septic Shock and Suppression of Tumor Necrosis Factor α and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid Ruth Gallily1,
Aviva Yamin1, Departments of Immunology The Hebrew University, Faculty of Medicine, Jerusalem, Rehovot, Israel.
(3)(Cannabinoid derivatives US patent 20070179135 A14);
(4) Treatment of HIV and diseases of immune dysregulation US 20080108647 A1”)
(5) https://www.polityka.pl/tygodnikpolityka/nauka/1947422,1,polka-odkryla-jak-uklad-odpornosciowy-walczy-z-sars-cov-2.read?fbclid=IwAR3JqN1NVPloroe23amozitWc7eXq5Qu3qG0J94eZ0kBCwiUZN65lP-_s9A
* Additional info by the article author